Summary
Parapharma Susta 350, an injectable product formulated with a blend of testosterone esters, underwent independent analysis to confirm its composition and dosing accuracy. The sample, identified by batch number PARA002 with an expiration date of August 2022, was submitted and funded by AnabolicLab.com for testing at SIMEC AG, a well-regarded pharmaceutical analysis laboratory.
The results revealed a total measured concentration for each testosterone ester that complied with the label specifications, with slight variances noted. Microbiological safety was confirmed, with no detectable contamination.
Detailed Report
Product Overview
- Manufacturer: Parapharma
- Product Name: Susta 350
- Batch Number: PARA002
- Expiration Date: August 2022
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: C 67087
- Testing Ordered: 28 February 2018
- Sample Received: 28 February 2018
- Analysis Conducted By: SIMEC AG
- Product Submitted By: AnabolicLab.com
- Analysis Paid For By: AnabolicLab.com
Testing Results
| Compound | Specification (Label Claim) | Measured Concentration | Accuracy | Variance | Compliance |
|---|---|---|---|---|---|
| Testosterone Enanthate | 200 mg/ml | 192.0 mg/ml | 96.0% | -4.0% | Yes |
| Testosterone Cypionate | 100 mg/ml | 112.1 mg/ml | 112.1% | +12.1% | Yes |
| Testosterone Propionate | 50 mg/ml | 58.2 mg/ml | 116.4% | +16.4% | Yes |
| Microbiological Testing | Result | Specification |
|---|---|---|
| TAMC | <1 KBE/ml | Complies |
| TYMC | <1 KBE/ml | Complies |
Evaluation of Independent Testing
The analysis confirms that Parapharma Susta 350 aligns closely with its label claims, with all tested testosterone esters falling within acceptable ranges for pharmaceutical accuracy. The measured concentrations indicate precise formulation, and the microbiological tests confirm the product’s safety for use. However, slight variances were observed, particularly an overdosage in Testosterone Propionate and Testosterone Cypionate.
Manufacturer-submitted samples may not reflect overall product consistency. Broader, independent testing across multiple batches sourced from the market is essential to validate product reliability and consistency further.
Conclusion
Parapharma Susta 350 exhibited high accuracy in its measured testosterone ester concentrations, with a slight variance in two esters that exceeded the label claims. These findings suggest high manufacturing standards while emphasizing the importance of continued third-party testing to ensure consistent quality across all batches. This report supports transparency and harm reduction initiatives.
Disclaimer
This report is published for educational and harm reduction purposes. The findings pertain solely to the tested batch and may not represent other products under the same name. Readers are encouraged to critically assess these results alongside additional independent testing to ensure informed decision-making.
Discuss the ParaPharma Susta 350 lab test results on the AnabolicLab Forum.
(The following images are photographs of the actual product that was submitted for testing.)
